BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18765801)

  • 1. A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses.
    Chen MW; Cheng TJ; Huang Y; Jan JT; Ma SH; Yu AL; Wong CH; Ho DD
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13538-43. PubMed ID: 18765801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent adjuvant effects of novel NKT stimulatory glycolipids on hemagglutinin based DNA vaccine for H5N1 influenza virus.
    Hung JT; Tsai YC; Lin WD; Jan JT; Lin KH; Huang JR; Cheng JY; Chen MW; Wong CH; Yu AL
    Antiviral Res; 2014 Jul; 107():110-8. PubMed ID: 24786174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Broadly neutralizing DNA vaccine with specific mutation alters the antigenicity and sugar-binding activities of influenza hemagglutinin.
    Chen MW; Liao HY; Huang Y; Jan JT; Huang CC; Ren CT; Wu CY; Cheng TJ; Ho DD; Wong CH
    Proc Natl Acad Sci U S A; 2011 Mar; 108(9):3510-5. PubMed ID: 21321237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A triclade DNA vaccine designed on the basis of a comprehensive serologic study elicits neutralizing antibody responses against all clades and subclades of highly pathogenic avian influenza H5N1 viruses.
    Zhou F; Wang G; Buchy P; Cai Z; Chen H; Chen Z; Cheng G; Wan XF; Deubel V; Zhou P
    J Virol; 2012 Jun; 86(12):6970-8. PubMed ID: 22496212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cocktail of H5N1 COBRA HA vaccines elicit protective antibodies against H5N1 viruses from multiple clades.
    Crevar CJ; Carter DM; Lee KY; Ross TM
    Hum Vaccin Immunother; 2015; 11(3):572-83. PubMed ID: 25671661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broad humoral and cellular immunity elicited by a bivalent DNA vaccine encoding HA and NP genes from an H5N1 virus.
    Xu K; Ling ZY; Sun L; Xu Y; Bian C; He Y; Lu W; Chen Z; Sun B
    Viral Immunol; 2011 Feb; 24(1):45-56. PubMed ID: 21319978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A single immunization with HA DNA vaccine by electroporation induces early protection against H5N1 avian influenza virus challenge in mice.
    Zheng L; Wang F; Yang Z; Chen J; Chang H; Chen Z
    BMC Infect Dis; 2009 Feb; 9():17. PubMed ID: 19216752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A recombinant H7N9 influenza vaccine with the H7 hemagglutinin transmembrane domain replaced by the H3 domain induces increased cross-reactive antibodies and improved interclade protection in mice.
    Wang Y; Wu J; Xue C; Wu Z; Lin Y; Wei Y; Wei X; Qin J; Zhang Y; Wen Z; Chen L; Liu GD; Cao Y
    Antiviral Res; 2017 Jul; 143():97-105. PubMed ID: 28408133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monovalent H5 vaccine based on epitope-chimeric HA provides broad cross-clade protection against variant H5N1 viruses in mice.
    He F; Prabakaran M; Rajesh Kumar S; Tan Y; Kwang J
    Antiviral Res; 2014 May; 105():143-51. PubMed ID: 24637255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.
    Mayrhofer J; Coulibaly S; Hessel A; Holzer GW; Schwendinger M; Brühl P; Gerencer M; Crowe BA; Shuo S; Hong W; Tan YJ; Dietrich B; Sabarth N; Savidis-Dacho H; Kistner O; Barrett PN; Falkner FG
    J Virol; 2009 May; 83(10):5192-203. PubMed ID: 19279103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polyvalent DNA vaccines expressing HA antigens of H5N1 influenza viruses with an optimized leader sequence elicit cross-protective antibody responses.
    Wang S; Hackett A; Jia N; Zhang C; Zhang L; Parker C; Zhou A; Li J; Cao WC; Huang Z; Li Y; Lu S
    PLoS One; 2011; 6(12):e28757. PubMed ID: 22205966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Clade-Specific and Broadly Reactive Live Attenuated Influenza Virus Vaccines against Rapidly Evolving H5 Subtype Viruses.
    Boonnak K; Matsuoka Y; Wang W; Suguitan AL; Chen Z; Paskel M; Baz M; Moore I; Jin H; Subbarao K
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28490598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective immunity elicited by a pseudotyped baculovirus-mediated bivalent H5N1 influenza vaccine.
    Wu Q; Xiao S; Fan H; Li Y; Xu J; Li Z; Lu W; Su X; Zou W; Jin M; Chen H; Fang L
    Antiviral Res; 2011 Dec; 92(3):493-6. PubMed ID: 22020305
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress toward a universal H5N1 vaccine: a recombinant modified vaccinia virus Ankara-expressing trivalent hemagglutinin vaccine.
    Prabakaran M; Leyrer S; He F; Auer S; Kumar SR; Kindsmueller K; Mytle N; Schneider J; Lockhart S; Kwang J
    PLoS One; 2014; 9(9):e107316. PubMed ID: 25229722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in mice.
    Luo M; Tao P; Li J; Zhou S; Guo D; Pan Z
    J Virol Methods; 2008 Dec; 154(1-2):121-7. PubMed ID: 18789973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutralizing epitopes of influenza virus hemagglutinin: target for the development of a universal vaccine against H5N1 lineages.
    Prabakaran M; He F; Meng T; Madhan S; Yunrui T; Jia Q; Kwang J
    J Virol; 2010 Nov; 84(22):11822-30. PubMed ID: 20844051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Codon optimization of antigen coding sequences improves the immune potential of DNA vaccines against avian influenza virus H5N1 in mice and chickens.
    Stachyra A; Redkiewicz P; Kosson P; Protasiuk A; Góra-Sochacka A; Kudla G; Sirko A
    Virol J; 2016 Aug; 13(1):143. PubMed ID: 27562235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Replication-Defective Influenza Virus Harboring H5 and H7 Hemagglutinins Provides Protection against H5N1 and H7N9 Infection in Mice.
    Tian X; Landreth S; Lu Y; Pandey K; Zhou Y
    J Virol; 2021 Jan; 95(3):. PubMed ID: 33177192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.